Tom W. Huizinga

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications

When one joint matters: the monoarticular blind spot in inflammatory arthritis.

When one joint matters: the monoarticular blind spot in inflammatory arthritis.

Journal: The Lancet. Rheumatology
Published: February 15, 2026

Is AI-assisted active learning software able to reliably speed-up systematic literature reviews in rheumatology? A real-time comparison of AI-assisted and manual abstract selection.

Is AI-assisted active learning software able to reliably speed-up systematic literature reviews in rheumatology? A real-time comparison of AI-assisted and manual abstract selection.

Journal: RMD open
Published: November 14, 2024

Value of the 6 min walk test in detecting cardiopulmonary involvement in patients with systemic sclerosis.

Value of the 6 min walk test in detecting cardiopulmonary involvement in patients with systemic sclerosis.

Journal: RMD open
Published: November 05, 2024

Rheumatoid arthritis-associated interstitial lung disease in countries across the world.

Rheumatoid arthritis-associated interstitial lung disease in countries across the world.

Journal: Seminars in arthritis and rheumatism
Published: July 22, 2024

Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: results from the phase 2a IRIS-RA study.

Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: results from the phase 2a IRIS-RA study.

Journal: RMD open
Published: February 27, 2024

Troponin I levels in systemic sclerosis patients with myocardial involvement.

Troponin I levels in systemic sclerosis patients with myocardial involvement.

Journal: Journal of scleroderma and related disorders
Published: January 05, 2024

Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023.

Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023.

Journal: Annals of the rheumatic diseases
Published: August 24, 2023

Long-term mortality in treated-to-target RA and UA: results of the BeSt and IMPROVED cohort.

Long-term mortality in treated-to-target RA and UA: results of the BeSt and IMPROVED cohort.

Journal: Annals of the rheumatic diseases
Published: August 04, 2023

Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II association.

Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II association.

Journal: RMD open
Published: July 07, 2023

Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time?

Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time?

Journal: Annals of the rheumatic diseases
Published: April 07, 2023

Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosis.

Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosis.

Journal: RMD open
Published: March 10, 2023

The long-term course of the Health Assessment Questionnaire in patients with systemic sclerosis.

The long-term course of the Health Assessment Questionnaire in patients with systemic sclerosis.

Journal: Journal of scleroderma and related disorders
Published: November 08, 2022
Showing 1-12 of 72

Last Updated: 09/26/2026